Nn MedicalVoice
Editor in Chief Dr KK Aggarwal, Padma Shri Awardee                                                                               Dated:19 June,2020

Treating COVID patients with blood plasma from those recovered is safe, says study

Washington D.C: Treating patients suffering from coronavirus infection with transfusion of blood plasma from those who already recovered from the disease have been found to be safe and beneficial, a study suggested.
The new study, conducted over 20,000 hospitalized covid-19 patients, was based on a century-old idea in medicine that has been used against measles, influenza and Ebola. The treatment, also called convalescent plasma, found that people who recover from infection have virus-fighting antibodies floating in their blood, and transfusions of their plasma -- the clear liquid after blood cells are removed -- may give recipients' immune systems an assist in fighting off the virus, The Washington Post reported....read more


CMAAO Coronavirus Facts and Myth Buster 131- HCQS in Diabetes

950: HCQS in diabetes
In 2014, hydroxychloroquine 400 mg got DCGI approval as additional indication as an adjunct to diet and exercise to improve glycemic control of patients on metformin, sulfonylurea combination in type 2 diabetes.,Then why it cannot be given as a routine in all patients with metabolic syndrome with COVID evidence?
Among patients with rheumatoid arthritis (RA) or psoriasis, use of anti-inflammatory, disease-modifying antirheumatic drugs, such as TNF inhibitors and hydroxychloroquine, is associated with a lower incidence of diabetes than other agents....read more


World Covid Meter 18th June - 213 Countries affected; Crosses 8 Million, Doubling Rate 8 days

Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8; 5M May 20, 6M May 30, 7M June 7, 8M by June 15
Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity
Doubling time India 17 days, USA 33 days, Brazil 13 days, Russia 18 days, Spain 47 days, UK 35 days, Italy 55 days, France 49 days, Turkey 37 days
Likely minimum deaths (451236 + 54453 x 15 = 8168) = 459403,Coronavirus Cases: 8,398,619 ,Deaths: 451,236,Recovered: 4,414,672,ACTIVE CASES: 3,532,711....read more


Win Relationships and Not Arguments

It is a well-known saying that when you are arguing with a wrong boss, you may win the argument but you may invariably lose the relationship and not argument. Lord Krishna was born after Lord Rama and Krishna taught us when to say ‘sorry’ even if you are not at fault. Never hurt the ego of a person who is under influence of alcohol or boss when he is angry. ....read more


Video of The day

Mumbai Experience of COVID with Shashank Joshi


Medbytes

       


Healthcare News Monitor
Pharma API imports from China: India moving towards self-reliance
business Line

India is moving towards reducing dependency on the import of Active Pharmaceutical Ingredients (APIs) and drug intermediates from China. “There has been a 4 per cent reduction in import of APIs and other raw materials from China in the last one year,” R Uday Bhaskar, Director-General, Pharmaceutical Export Promotion Council (Pharmaexcil), told Business Line.
About 65 per cent of the raw materials for Indian drug makers worth $3.5 billion are being sourced from China

Cipla expands partnership with Roche Pharma India
Business Standard

Cipla signed a distribution agreement with Roche Products (India) to expand scope of the partnership to include, marketing and distribution of Roche's trademark oncology drugs. ,The announcement was made after market hours yesterday. Shares of Cipla rose 0.16% to end at Rs 641.55 on Thursday.
Cipla and Roche Products (India) Pvt. Ltd. (Roche Pharma) yesterday announced that the two companies have entered into an agreement to provide better access to innovative medicines for patients in India. Under this agreement, Cipla will be responsible for marketing and distribution of Roche Pharma's key trademark oncology drugs viz.,Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova).

Is India Fighting COVID-19 or Its Own Doctors?
FITDR ASHWINI SETYA

As India gallops to the number 4 position in the world as far as the number of COVID 19 cases is concerned and records over 12,000 deaths, the shabby treatment meted out to health care workers (HCW), especially the doctors, is becoming increasingly apparent. The situation has grown from bad to worse ever since the first case was reported from India on January 30, 2020.
Protection in the form of donning personal protective equipment (PPE) is the least that is required to protect the so-called frontline warriors. As the pandemic broke out in India, there was a dearth of PPE and consequently a huge gap between the supply and demand. Despite the Supreme Court order of 8th of April, 2020 to ensure the supply of PPE to the HCW, the ground reality is that the demand far exceeded the supply until recently, exposing many to the deadly virus.

76 Soldiers Injured In Ladakh Clash, All Recovering: Army Officials
NDTV

New Delhi: Seventy-six soldiers of the army, who were injured during the clash with Chinese troops at Ladakh's Galwan Valley on Monday evening are at various hospitals, army officials have told NDTV. None of them are critical at the moment and all of them should be able to get back on duty, the officials said.
Of the injured soldiers, 18 are at the hospital in Leh who are expected at their posts within 15 days. The remaining 56 are spread across other hospitals, who can join work in a week, the officials said.,Twenty soldiers had died in the clash on Monday evening that started after the Indian troops, led by Colonel BK Santosh Babu, tried to remove a tent belonging to Chinese troops.